Microscopic iron particles that activate in the human body system fight cancer cells. This statement was made by scientists from Stanford University. Before the drug ferumoxytol of iron nanoparticles was used only in the treatment of iron deficiency anemia.
Preliminary tests proved that the medication penetrates cancerous cells. If you associate the nanoparticles with the chemotherapy, it is possible to obtain medium with high selectivity when chemotherapy acts only on cancer cells. Healthy tissue while suffering minimal.
Experiment on laboratory rats confirmed the assumption of scientists. Ferumoxytol reduced tumor size and increased life span of animals.
At the moment, the drug has passed all necessary tests and is approved for the treatment. It remains only to obtain permission for the use of funds in Oncology.